Scope of Drug Designing: Open Access Journal
Scope of Drug Designing: Open Access Journal
Drug Designing: Open Access is an international peer reviewed open access journal presenting original research and contributions and scientific advances in the field of drug design and development. Drug Designing journal welcomes research articles, review articles, letter to the editors, editorials, case reports and innovations relating to all aspects of drug design and dev... Read More
Statistical Designs for Pharmaceutical
Risk Factors for Febrile Seizures in Children
Objective: we aimed to identify the factors associated with febrile seizures (FS) occurrence.
Methods: This was a case-control study. Sixty cases of FS were prospectively recorded and compared to 60 controls admitted for fever without seizures. Baseline Data were collected from all consecutive patients and laboratory hematological parameters including complete blood count, serum iron, serum ferritin and zinc levels were perform... 
The Presence of Autonomous and Non-Autonomous Replication in Cancer and their Connection through Inflammation
Targeted therapy with small molecule such as TKI (tyrosine kinase inhibitor) against EGFR has achieved high response rate and significant clinical benefits in selected group of lung cancer patients in the past decade. One reliable criterion for patient selection is the presence of certain mutations in the EGFR gene such as mutations in exon-19, 20 or 21 in lung cancer patients. In these patients, it is often observed that TKI therapy could be so effective ... 
On behalf of the “
Special Issue on Drug Designing : Edited by Guest Editors
The 
Pemphigus Herpetiformis with Only Positive Anti-Envoplakin Antibodies
Pemphigus herpetiformis, first described in 1975, is a rare subtype of autoimmune bullous disease that associates clinical features of dermatitis herpetiformis with immunological features of pemphigus. We present a 48-years-old female patient, with pruritic lesions located mainly in the upper limbs with 6 years of evolution. Physical examination revealed erythematous papules, some excoriated and vesicles of translucent content distributed on her arms, trunk and neck. Histological examination of ... 
Autoimmune Hemolytic Anemia and Thrombocytopenia with Tuberculous Lymphadenitis
Well-differentiated small-intestinal neuroendocrine tumors (SI-NETs) tend to be biologically indolent.Despite this tendency, they have a predilection for metastasis. Peritoneal involvement is quite common as isunfortunately peritoneal carcinomatosis (PC). PC is a dreaded metastatic complication due to the significant morbidity it creates for patients as well as well as increasing their mortality risk. The risk factors for PC development in SI-NETs remain understudied; however, on... 
Journal of Drug Designing: Open Access | Celebrating 9th Anniversary
Journal of Biology and Todays World is a perfect Insight for the readers related to Biology and Medicine. It has a vast scope and is currently running since 8 years with many successful quality articles published. Due its broad scope, a diverse set of topics, such as genetics, biotechnology, biochemistry, microbiology, cellular & molecular biology, and disease biology, are covered under the aegis of this journal. Additionally, the journal also provides rapid, authoritative, and insightful reports and interpretation of topical and future trends in science.
... 
Highlights on Drug Designing
The Journal, 
Reviewing the progression in Drug Designing research
The team “
Pathology: A big innovation to medicine
Journal of Medical and Surgical Pathology (JMSP) has announced almost 20 percent discount on article processing charge to commemorate its 4th Anniversary.
The Editorial Board of Journal of Medical and Surgical Pathology is overwhelmed by the response and eagerness of the academic and research contributors to publish with the journal and take part in the 4th anniversary celebrations. During this year we look forward to taking some initiatives that would encourage and rewar... 
On behalf of the Journal of Developing Drugs, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been ten long years we have started the Journal, now we are celebrating the 
Alopecia is not a well-known adverse effect of second-line anti-tuberculosis drugs. It is, however, been frequently reported in Eritrea and 83% of the reports of alopecia associated with second-line anti-TB drugs in the global adverse drug reaction database, as of July 25, 2017, were submitted from Eritrea. It is wondering why this much variation is happening and this study is therefore aimed at quantifying the risk, identifying possible risk factors and elucidating the causal association between alopecia and the second-line anti-TB drugs in Eritrea. This was an observational cohort study o... 
On behalf of the 
The